Idea Description
Supplementary Information
Detailed Submission Data
Innovation 'Elevator Pitch':
ConCERT-D is an integrated clinical & research solution designed with Dementia leading clinical experts specifically for the treatment, identification & management of dementia patients, providing results and medication management. 
Overview of Innovation:
ConCERT-D displays captured mental assessment scores for tests including the Mini Mental State Examination (MMSE) in a graphical way enabling Clinicians to relate fluctuations in scores with events that would have happened in the meantime

The medication module allows Clinicians to keep track of the patient diagnosis, prescribed drugs, related side effects, allergies and other conditions. The in-built drug formulary is specially geared towards dementia patients. The accumulative anticholinergic cognitive burden (ACB) is automatically calculated allowing Clinicians to take better decisions, ultimately reducing the risks of cognitive impairment & death

The medication module enables Clinicians to check the dosages for antidepressants and anti-psychotics being taken by the patient as a percentage of the maximum dosage set for these medications

A Research Register for Clinicians to inform Clinical practice
The ability to easily identify patients and carers that match a clinical trial’s participation criteria provides a highly effective tool to increase participation in research. Researchers can build the appropriate participation criteria for clinical trials in ConCERT-D. The system can automatically report on patients that are eligible for participation in studies

Once a patient is identified the clinical researchers speaks to their carers for advice. In some cases internal background checks, tests and screening are carried out. If a patient is found to be suitable and willing to take part he/she is enrolled onto the clinical trial. On the other hand if found unsuitable the reason why is logged and the patient is automatically excluded from subsequent participant searches for that trial

ConCERT-D facilitates accreditation in programs including as The Memory Services National Accreditation Program (MSNAP) allowing hospitals to benchmark their services against national standards and provide quality assurances. MSNAP also enables staff to ensure they are making a meaningful difference to people’s lives as well as supporting implementation of national clinical excellence guidelines. ConCERT-D supports Clinicians to capture MSNAP information during interactions with the patient & then generate reports with the information gathered

These reports allow the identification of trends, assessment of completeness & are of great use for assessors when rewarding accreditation. This functionality can be adapted to other similar accreditation programs
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
Similar Content2
Innovation 'Elevator Pitch':
Yecco is a fully digital telehealth & telecare self-management platform for monitoring all aspects of a person’s past & real-time health status. Our products also allow environmental monitoring & home automation to enable full remote care & support.
Overview of Innovation:
Yecco brings new & exciting ways of data sharing as the trend moves towards patients managing their health & taking control of their health data.

Our solutions facilitate self-management of chronic conditions & can help to reduce emergency readmissions to hospital. In 2012-13 more than 1 million emergency readmissions within 30 days of discharge cost an estimated £2.4 billion.* Yecco can be used to support hospital discharge as it monitors the safety & health of a person living when back in their own home. 

View our video & see how Yecco can support a patient with Diabetes & COPD –

Yecco’s own private, social network allows its patients, health & care professionals to share medical & device information with any connection they wish, enabling consumers, health & care professionals to share real-time medical & device data. It can be used at home, work, care settings, medical & care facilities.

Features include:
  • Share medical data with chosen family, friends & clinicians
  • Ability for another person to manage your profile
  • Create & send group messages & on your timeline
  • Keep a check on your health in real time using the Yecco medical devices or add readings manually
  • Add thresholds to alert chosen connections 
  • Store personal, medical & medication information
  • Built in calendar & reminder support
  • Video to stay in contact/facilitate remote consultations
  • Message facility
  • Task planner
  • Group connection
  • Educational content
  • Response questionnaires    
Yecco medical devices can measure vital signs with accuracy & precision using Bluetooth to automatically connect to an iOS or Android device(s) using the Yecco App for a simple & effortless measurement in real time.

The Yecco multi-function sensor offers power & flexibility that’s not been available before in a home sensor. Paired with the Yecco App & through the use of the Yecco Docking Station it can automatically detect abnormalities in physiological data, alerting chosen connections on the Yecco network.
The multi-function sensor can connect directly to the WIFI network. Features include the ability to activate the camera on the mobile device to investigate alerts.

  • Motion detection
  • Door & window open or closed status
  • Smoke detection
  • Carbon monoxide detection
  • Temperature & humidity
  • Add separately & plug in:
    • Bed occupancy sensing pad
    • Enuresis pad (to detect for moisture in a bed or chair)
    • Rechargeable battery
There is the option to keep a check on your health using the Yecco Wearable Watch.
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Long term conditions: a whole system, person-centred approach / Wellness and prevention of illness / Digital health
Benefit to NHS:
Rising demand for services, combined with restricted or reduced funding, is putting pressure on the capacity of local health and social care systems.
The NHS spends around £820 million a year treating older patients who no longer need to be there.
Yecco Pro App
Yecco Pro is a licensed cloud-based interface that enables organisations to remotely monitor multiple patients.
Yecco Pro gives medical professionals multi patient monitoring with real time data for early intervention. Powerful threshold and notification options assist all professionals to give improved patient outcomes and increased safety.

Features include:
  • Receives real time data for early intervention
  • Interface for clinician to patient communication
  • Set thresholds to assist in disease management and early intervention for improved patient outcomes and safety
  • Set alerts / notifications
  • Group patients
  • Filter and create reports (CSV)
  • Video conference calling
This modular platform enables Yecco to add other 3rd party modules or interface to Electronic Patient Record system or data contextualisation platforms that enable intelligent triage and diagnosis across a range of data sources

Yecco's product are currently being used by Surrey and Boarder Partnership testbed that is monitoring the health and wellbeing of patients that have mild o moderate levels of dementia. The aim of the project is to assist clients in monitoring and reduce the burden on front line NHS services. (GP’s appointments, health work home visit and hospital re-admissions). The health and wellbeing reading take form the Yecco devices is being monitor in partnership with the KSSAHSN/University of Surrey. Currently awaiting health economics stats and data from project.
Online Discussion Rating
4.00 (2 ratings)
Initial Review Rating
5.00 (1 ratings)
Benefit to WM population:
The past few decades have seen significant improvements in life expectancy, however, rising longevity brings increasingly complex & chronic health conditions, placing substantial demands on health & social care services.
At the same time services are experiencing significant financial pressure & need to find ways of lowering costs while maintaining or improving the quality of care provided.
This requires new ways of working in order to meet increasing demand & deliver care that is safe & cost‑effective while reducing reliance on hospital & institutional based care.
Technology can help to support these new ways of working.
When hospital discharge goes wrong it comes at significant cost both to individuals & to the health and social care system. In 2012-13 there were more than 1 million emergency readmissions within 30 days of discharge costing an estimated £2.4 billion. Source:

The number of older people in England is increasing rapidly, by 20% between 2004 & 2014 & with a projected increase of 20% over the decade to 2024. Hospitals have also experienced increases in the number of emergency admissions of older patients, by 18% between 2010-11 & 2014-15. Older patients now account for 62% of total bed days spent in hospital.
The relative growth in numbers of older people is important. The number of older people with an emergency admission to hospital increased by 18% between 2010-2011 & 2014-15 (compared with a 12% increase overall).
While NHS spending has grown by 5% in real terms between 2010--11 & 2014-15, local authority spending on adult social care has reduced by 10% in real terms since 2009-10.  Source:
Yecco is an innovative solution that monitors the safety & health of a person living in their own home or in a care setting.  This combined telehealth & telecare solution can enable health & care providers to meet the health & social care needs of individuals in their charge.
By using Yecco technology to monitor if a person is physically safe, for example that they have not left the cooker on or had a fall, as well as critical indicators such as blood pressure or blood oxygen levels to indicate that they are not medically at risk can improve user’s quality of life & reduce long-term health care costs.

Yecco can help to keep people safe in their own home & reduce the number of unnecessary hospital visits, increase confidence in users to manage their own health & alleviate the pressures & concerns of caregivers.
Current and planned activity: 
We wish to work with regional health & care providers & WMAHSN's Patient Safety Collaborative & Care Home Network. We also wish to explore if our technology can be used to support Mental Health Services, possibly to monitor & support patients coming off medication.
Our products are being used by Surrey & Boarder Partnership testbed to monitor the health & wellbeing of patients with mild to moderate levels of dementia. The project's aim is to assist clients in monitoring & reduce the burden on front line NHS services (GP appts, health work home visit & hospital re-admission). The health & wellbeing readings taken from Yecco devices is being monitored in partnership with KSSAHSN/University of Surrey.
We previously demonstrated our products & services to EMAHSN & are currently involved in the Falls Prevention tender (EMAHSN led). Yecco products & services have been purchased by Neath & Port Talbot Borough Council to monitor & support regional LD clients (awaiting deployment date).       
What is the intellectual property status of your innovation?:
Yecco has developed its software and applications and retains the IP to this. It also owns IP in some of the hardware products developed in-house (sensors and IoT gateways). Some 3rd party integrated products (such as generic medical devices for vital sign monitoring are not Yecco IP). These products are in the process of being further protected. 

Yecco is currently in use in the NHS England IoT testbed with Surrey and also within other local authorities. Our products comply with the required data model, structure, coding and security requirements that have been dictated. We are also working with established telecare and telehealth organisations where compliance is required / requested to various standards and integration with 3rd party alarm management systems.
Return on Investment (£ Value): 
Return on Investment (Timescale): 
1 year
Ease of scalability: 
Yecco are currently involved in Surrey and boarder partnership NHS foundation trust testbed programme for monitoring patients with mild to moderate dementia. The project is currently ongoing. yecco have requested information relating to the impatch of the project and health economic details. As soon as this information has been published yecco willl add this information into the meridian system 

Read more
Hide details
Innovation 'Elevator Pitch':
The Silhouette® solution enables integrated care ,closer to home, for patients with diabetic foot ulcers, using digital wound imaging and objective wound healing data available remotely in real time, to improve patient care and reduce system costs.
Overview of Innovation:
Digital Silhouette® solution for diabetes foot management improves clinical objectivity and patient experience 
Diabetes is a major health challenge in the UK with a rapidly increasing number of people affected. Active disease of the foot is a crisis situation for a patient with diabetes and requires timely referral and management. A proven solution for reliable and remote monitoring of diabetes foot ulcers, Silhouette, is available to support integrated care, releasing capacity in acute out-patient clinics and supporting safe care in community settings. 

An EMAHSN-supported demonstrator established with Derby Teaching Hospitals NHS Foundation Trust and Derbyshire Community Healthcare Services Trust has led to improvements in clinical management and patient experience:

Clinical Lead, Professor Fran Game, Consultant Diabetologist, Clinical Director R&D, Derby Teaching Hospitals NHS Foundation Trust:
“As a result of implementing the Silhouette system, we have been able to safely transfer an increasing portion of patients for treatment in community clinics and have improved waiting times in our out-patient clinic. Importantly, patients are happy with the new model of care. In a survey following introduction of digital ulcer assessment, 71% of patients reported a greater confidence in the care they had received.”
Service User, Patient Experience:
Patient A.S. from Kilburn said; “We only live just down the road from the clinic and it saves so much time for us, it is much closer to home than the hospital is, which means we are not spending so much time getting to and from appointments.”

Innovation Solution Deployed:
  • Silhouette® digital wound imaging & information system deployed as a telehealth solution, to build community capability for on-going treatment.
  • 3D measurement technology accurately maps ulcer size, enabling clinicians to assess wound progress & response to treatment with objective data
  • Enables reliable & remote monitoring of patients with active DFU & chronic complex wounds
Impacts to date:
  • EMAHSN independent qualitative and quantitative evaluation
    –Over-whelming improvement in patient experience
    –Positive feedback from clinicians
    –Reduction in acute Out-Patient over-crowding
    First year 462 (7.4%) appointments moved to community
    First year 5 camera, total investment £66k, first year savings £35k
    Business case based upon reduction in treatment/tariff costs

SilhouetteStar Camera

Dr Bruce Davey - CEO ARANZ Medical with SilhouetteStar Camera


Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Long term conditions: a whole system, person-centred approach / Wealth creation / Digital health / Innovation and adoption / Patient and medicines safety / Person centred care
Benefit to NHS:
The Silhouette digital solution for diabetes foot management has been successfully deployed in an EMAHSN-supported Demonstrator. The deployment of Silhouette is enabling an integrated diabetes foot pathway in Southern Derbyshire , linking care across acute and community.
A Business Case is available on request from EMAHSN, please email 
The reported benefits to date include:
Patient outcomes: Greater convenience for patients, through treatment in community, less time waiting, less travel, with remote oversight by specialists to provide joined up care
Efficiency gains: health care professionals can access the secure Silhouette digital data quickly and in real time allowing escalation and de-escalation from community to hospital based on objective clinical data on ulcer status and risk. Adminstration reduced with automated reporting of patient's ulcer treatment and progress to GPs, reducing admin time and cost of letters to GPs.
Cost-effectiveness: A shift of hospital treatment appointments to community, trending at 8% has yielded savings on tariff costs across whole system. Cost reduction on adminstration involved with reporting to GPs.  
Online Discussion Rating
5.00 (1 ratings)
Initial Review Rating
4.80 (2 ratings)
Benefit to WM population:
Health: Using objective clinical data on ulcer healing to building efficiency in acute out-patients, building community capability for care closer to home to support improvements in patient safety, experience and outcomes.
Wealth: Better use of NHS funds to enable staff to manage patients with a focus on outcomes rather than activity 
Growth of a UK SME to create jobs and new solutions for the NHS.
Current and planned activity: 
Current activity: 
Entec Health and ARANZ Medical are actively engaging with expansion of Silhouette deployment across Derbyshire county as part of the Derbyshire NHSE Diabetes Transformation programme. In addition, a number of other NHS Diabetes Foot Services are working with us to develop and deploy a Silhoeutte-enabled MDFT in Nottinghamshire and Cambridgeshire & Peterborough. These initiatives involve CCG /STP stakeholders to support sustainability plans for the innovation and transformation work for long-term gain for patients and the NHS.
Planned activity
We are seeking to work with CCGs/STPs and NHS Providers who have a vision for deploying Silhouette in diabetes foot ulcer management and chronic wound management to drive forward a patient-centred, outcomes-led, service. 
What is the intellectual property status of your innovation?:
Silhouette digital wound assessment and information management system is developed and manufactured by ARANZ Medical Limited, based in New Zealand, with ARANZ Medical Limited having ownership of IP for Silhouette brand and Silhouette technology.

Return on Investment (£ Value): 
Return on Investment (Timescale): 
2 years
Ease of scalability: 
Regional Scalability:
Please describe how the innovation could be scaled across the WM region. Have you implemented at scale in any other regions?
What outcomes are you hoping to achieve and what are the measures that you will use to gauge the success of the innovation and how will these assessments be made? Please ensure that you have quality, safety, cost and people measures.
Adoption target:
What are the targets for adoption across the WM and what are the minimum viability levels?
Read more
Hide details

Created by

Share and Follow